Thousands in England unable to access weight loss jabs via GP, figures reveal

Doctors say NHS rollout not fit for purpose with fewer than half of commissioning bodies prescribing Mounjaro

Thousands of patients in England are unable to access weight loss jabs via their GP, figures reveal, as doctors warn that the NHS rollout is “not fit for purpose”.

Family doctors got the green light to prescribe the drugs for the first time in June. About 220,000 people with “greatest need” were set to receive Mounjaro, also known as tirzepatide and made by Eli Lilly, on the NHS over the next three years.